Duodenal administration of solid lipid nanoparticles loaded with different percentages of tobramycin
- 1 May 2003
- journal article
- research article
- Published by Elsevier in Journal of Pharmaceutical Sciences
- Vol. 92 (5), 1085-1094
- https://doi.org/10.1002/jps.10368
Abstract
No abstract availableKeywords
This publication has 22 references indexed in Scilit:
- Intestinal lymphatic drug transport: an updateAdvanced Drug Delivery Reviews, 2001
- Effect of Short‐, Medium‐, and Long‐Chain Fatty Acid‐Based Vehicles on the Absolute Oral Bioavailability and Intestinal Lymphatic Transport of Halofantrine and Assessment of Mass Balance in Lymph‐Cannulated and Non‐cannulated RatsJournal of Pharmaceutical Sciences, 2000
- Solid lipid nanoparticles (SLN) for controlled drug delivery – a review of the state of the artEuropean Journal of Pharmaceutics and Biopharmaceutics, 2000
- Body Distribution of Camptothecin Solid Lipid Nanoparticles After Oral AdministrationPharmaceutical Research, 1999
- Physicochemical characterization of lipid nanoparticles and evaluation of their drug loading capacity and sustained release potentialJournal of Controlled Release, 1997
- Lymphatic uptake and biodistribution of liposomes after subcutaneous injection.Biochimica et Biophysica Acta (BBA) - Biomembranes, 1997
- Preparation of Biodegradable, Surface Engineered PLGA Nanospheres with Enhanced Lymphatic Drainage and Lymph Node UptakePharmaceutical Research, 1997
- Morphological observations on the fate of liposomes in the regional lymph nodes after footpad injection into ratsBiochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1996
- Drug Targeting Towards the LymphaticsPublished by Elsevier ,1991
- Nanocapsules as carriers for oral peptide deliveryJournal of Controlled Release, 1990